DataConnect Is Now Available Globally Across Six Major Digital Platforms
1.7.2021 12:48:00 EEST | Business Wire | Press release
DataConnect, the global initiative to enable viewing mixed-brand fleets in a single platform, is now live with an expanded line of six major digital platforms and available to farm operations around the world. Case IH, STEYR and New Holland now join John Deere, CLAAS and the European farm management platform 365FarmNet, which launched the feature late last fall.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005365/en/
DataConnect is a collaboration between CNH Industrial, John Deere, CLAAS and 365FarmNet to enable farms to view all their vehicles within a single digital platform of their choice. Illustration: DataConnect brands
Any farm operations using any self-propelled forage harvesters, combines or tractors from the participating brands now can view it all in one participating platform. Previously, viewing such information required managing additional portal for each brand involved.
With this new approach, customers can view five different machinery data parameters from their machine fleet:
- current machine location
- historical machine position
- fuel tank level
- status of the machine in the field
- machine speed
Any farm operator/owner who want to use the option simply needs to provide themselves with the permission to view all equipment in the platform that is most convenient for them. Once connected, the machines of the other manufactures appear automatically in that portal. The vehicles are even displayed with icons in the respective brand colors.
DataConnect works without any additional hardware and software components and ensures secure data handling. The solution will apply to hundreds of thousands of already connected machines.
The addition of CNH Industrial means that users of AFS Connect, the telematics platform of Case IH, MyPLM Connect for New Holland, and S-Tech for STEYR, will have the option for the cloud-to-cloud exchange of data with both John Deere Operations Center and CLAAS TELEMATICS or 365FarmNet portals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210701005365/en/
Contact information
John Deere Walldorf GmbH & Co. KG, Impexstraße 3, 69190 Walldorf,
Ralf Lenge, phone: +49 171 4161599, e-mail: LengeRalf@JohnDeere.com
365FarmNet Group KGaA mbH & CoKG, Hausvogteiplatz 10, 10117 Berlin,
Yasmin Möhring, phone: +49 151 172 81 869 e-mail: moehring@365farmnet.com
CLAAS KGaA mbH, Mühlenwinkel 1, 33428 Harsewinkel,
Matthias Mumme, phone: +49 5247/12-2288, e-mail: matthias.mumme@claas.com
CNH Industrial, United States
Dan Danford, phone: +1 (262) 321-8856, e-mail: dan.danford@cnhind.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 13:17:00 EEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 12:11:00 EEST | Press release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 10:00:00 EEST | Press release
The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 09:00:00 EEST | Press release
As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom